Thursday, March 27, 2014
Publication and contact
Rational design platform to
generate dual-acting kinase and bromodomain inhibitors
In vitro studies suggest dual-acting kinase and bromodomain
inhibitors can be rationally designed to treat cancer and inflammatory
disease. In vitro, 9 of 628 structurally diverse kinase inhibitors
potently inhibited bromodomain
containing 4 (BRD4).
In cultured multiple myeloma (MM) cells, two dual-acting kinase inhibitors
suppressed expression of c-Myc
marker of BRD4 inhibition-whereas compounds that blocked the same kinase
targets without inhibiting BRD4 did not. Structural studies suggested
pharmacophores for the kinase and bromodomain inhibitory activities
overlapped but had distinct features, so the activities could be
independently optimized. Next steps include synthesizing inhibitors with
potency optimized for both target classes.
Published online March 27, 2014
licensing status not applicable
Ciceri, P. et al. Nat.
Chem. Biol.; published online March 2, 2014;
Contact: Stefan Knapp, University of Oxford, Oxford, U.K.
Contact: Daniel K. Treiber,
Corp., San Diego, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]